Literature DB >> 22564544

Differential roles of proteasome and immunoproteasome regulators Pa28αβ, Pa28γ and Pa200 in the degradation of oxidized proteins.

Andrew M Pickering1, Kelvin J A Davies.   

Abstract

The response and functions of proteasome regulators Pa28αβ (or 11S), Pa28γ and Pa200 in oxidative-stress adaptation (also called hormesis) was studied in murine embryonic fibroblasts (MEFs), using a well-characterized model of cellular adaptation to low concentrations (1.0-10.0 μM) of hydrogen peroxide (H(2)O(2)), which alter gene expression profiles, increasing resistance to higher levels of oxidative-stress. Pa28αβ bound to 20S proteasomes immediately upon H(2)O(2)-treatment, whereas 26S proteasomes were disassembled at the same time. Over the next 24h, the levels of Pa28αβ, Pa28γ and Pa200 proteasome regulators increased during H(2)O(2)-adaptation, whereas the 19S regulator was unchanged. Purified Pa28αβ, and to a lesser extent Pa28γ, significantly increased the ability of purified 20S proteasome to selectively degrade oxidized proteins; Pa28αβ also increased the capacity of purified immunoproteasome to selectively degrade oxidized proteins but Pa28γ did not. Pa200 regulator actually decreased 20S proteasome and immunoproteasome's ability to degrade oxidized proteins but Pa200 and poly-ADP ribose polymerase may cooperate in enabling initiation of DNA repair. Our results indicate that cytoplasmic Pa28αβ and nuclear Pa28γ may both be important regulators of proteasome's ability to degrade oxidatively-damaged proteins, and induced-expression of both 20S proteasome and immunoproteasome, and their Pa28αβ and Pa28γ regulators are important for oxidative-stress adaptation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22564544      PMCID: PMC3384713          DOI: 10.1016/j.abb.2012.04.018

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  41 in total

1.  Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.

Authors:  Ulrike Seifert; Lukasz P Bialy; Frédéric Ebstein; Dawadschargal Bech-Otschir; Antje Voigt; Friederike Schröter; Timour Prozorovski; Nicole Lange; Janos Steffen; Melanie Rieger; Ulrike Kuckelkorn; Orhan Aktas; Peter-M Kloetzel; Elke Krüger
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

2.  Immunoproteasome deficiency alters retinal proteasome's response to stress.

Authors:  Stacy A Hussong; Rebecca J Kapphahn; Stacia L Phillips; Marcela Maldonado; Deborah A Ferrington
Journal:  J Neurochem       Date:  2010-03-14       Impact factor: 5.372

3.  The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes.

Authors:  Andrew M Pickering; Alison L Koop; Cheryl Y Teoh; Gennady Ermak; Tilman Grune; Kelvin J A Davies
Journal:  Biochem J       Date:  2010-12-15       Impact factor: 3.857

4.  Impairment of lon-induced protection against the accumulation of oxidized proteins in senescent wi-38 fibroblasts.

Authors:  Jenny K Ngo; Laura C D Pomatto; Daniela A Bota; Alison L Koop; Kelvin J A Davies
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-08-24       Impact factor: 6.053

5.  HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress.

Authors:  Tilman Grune; Betül Catalgol; Anke Licht; Gennady Ermak; Andrew M Pickering; Jenny K Ngo; Kelvin J A Davies
Journal:  Free Radic Biol Med       Date:  2011-06-24       Impact factor: 7.376

6.  Regulation of the 26S proteasome complex during oxidative stress.

Authors:  Xiaorong Wang; James Yen; Peter Kaiser; Lan Huang
Journal:  Sci Signal       Date:  2010-12-07       Impact factor: 8.192

Review 7.  REGgamma, a proteasome activator and beyond?

Authors:  I Mao; J Liu; X Li; H Luo
Journal:  Cell Mol Life Sci       Date:  2008-12       Impact factor: 9.261

8.  Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells.

Authors:  Srigiridhar Kotamraju; Sadis Matalon; Toshiyuki Matsunaga; Tiesong Shang; J M Hickman-Davis; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2005-11-17       Impact factor: 7.376

9.  Mitochondrial Lon protease is a human stress protein.

Authors:  Jenny K Ngo; Kelvin J A Davies
Journal:  Free Radic Biol Med       Date:  2009-01-15       Impact factor: 7.376

10.  The effect of oxygen on biochemical networks and the evolution of complex life.

Authors:  Jason Raymond; Daniel Segrè
Journal:  Science       Date:  2006-03-24       Impact factor: 47.728

View more
  63 in total

Review 1.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

Review 2.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

3.  Measuring redox effects on the activities of intracellular proteases such as the 20S Proteasome and the Immuno-Proteasome with fluorogenic peptides.

Authors:  Vicent Bonet-Costa; Patrick Y Sun; Kelvin J A Davies
Journal:  Free Radic Biol Med       Date:  2019-07-25       Impact factor: 7.376

4.  Oxidative stress adaptation with acute, chronic, and repeated stress.

Authors:  Andrew M Pickering; Lesya Vojtovich; John Tower; Kelvin J A Davies
Journal:  Free Radic Biol Med       Date:  2012-11-09       Impact factor: 7.376

Review 5.  Characterizing the dynamics of proteasome complexes by proteomics approaches.

Authors:  Robyn M Kaake; Athit Kao; Clinton Yu; Lan Huang
Journal:  Antioxid Redox Signal       Date:  2014-03-27       Impact factor: 8.401

Review 6.  Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.

Authors:  Rachel Raynes; Laura C D Pomatto; Kelvin J A Davies
Journal:  Mol Aspects Med       Date:  2016-05-04

Review 7.  Harnessing proteasome dynamics and allostery in drug design.

Authors:  Maria Gaczynska; Pawel A Osmulski
Journal:  Antioxid Redox Signal       Date:  2014-02-21       Impact factor: 8.401

8.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

9.  Proteasome Composition in Cytokine-Treated Neurons and Astrocytes is Determined Mainly by Subunit Displacement.

Authors:  Kara L Shanley; Che-Lin Hu; Oscar A Bizzozero
Journal:  Neurochem Res       Date:  2020-01-14       Impact factor: 3.996

Review 10.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.